Malignant Liver Neoplasm — Trials

Malignant Liver Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,123 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 908
Recruiting: 530
Ph III recruiting: 46
Growth YoY: +5.9%
Industry share: 20%
Top sponsor: Sun Yat-sen University
Termination share: 32.5%
Trials / 1,000 deaths: 30.4 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (459)

clinicaltrialsPublishedShowing 51–76 of 76 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03746249	Phase II of Lenvatinib Plus PD-1 Antibody for Advanced HCC	withdrawn	Phase 2	0	Sun Yat-sen UniversityOTHER	1	Apr 17, 2019	clinicaltrials
NCT02011126	Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors	withdrawn	Phase 2	0	Children's Oncology GroupNETWORK	0	Aug 7, 2018	clinicaltrials
NCT02702960